Real life effectiveness in patients with not optimally controlled asthma
Study identifier:NIS-RTW-SYM-2008/1
ClinicalTrials.gov identifier:N/A
EudraCT identifier:N/A
CTIS identifier:N/A
Study Complete
Official Title
Real life effectiveness in patients with not optimally controlled asthma: Symbicort SMART, or other ICS/LABA with as needed SABA
Medical condition
asthma
Phase
-
Healthy volunteers
No
Study drug
-
Sex
All
Actual Enrollment
842
Study type
Observational
Age
N/A
Date
Study Start Date: 01 Oct 2008
Primary Completion Date: 01 May 2011
Study Completion Date: 01 May 2011
Study design
Allocation: -
Endpoint Classification: -
Intervention Model: -
Masking: -
Primary Purpose: -
Verification:
Verified 01 Nov 2015 by AstraZeneca Pharmaceuticals
Sponsors
AstraZeneca Pharmaceuticals
Collaborators
-
Inclusion and exclusion criteria
Loading...
No locations available
| Arms | Assigned Interventions |
|---|---|
| 1 Asthma patients who were partly controlled or uncontrolled, need to step up, or adjust dose of the controller medications to ICS/LABA | - |
Contacts
Investigators
Principal Investigator
Robin Meng
AstraZeneca Taiwan
